• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent
 

News

News you can use
10 years

Ten years has gone by so quickly. When the company started, we limited ourselves to the study of pain and cognition. Now we offer specialist bespoke studies across multiple therapeutic indications including pain, depression, schizophrenia, epilepsy and neurodegeneration to clients all around the world. Science will always remain our passion, along with the drive to research and deliver life-changing medicines. Thank you very much for your support along the way, we hope to work with you for many years to come.

 

Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk


Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design